3rdPartyFeeds

Buy Sluggish Amazon Stock Ahead of Q4 Earnings on Possible 2020 Surge?

Amazon stock has fallen over 4% in the last six months. It appears that investors are worried about Amazon's profit. But how long will Amazon stock stay stagnant as the e-commerce powerhouse spends to speed up its delivery? Read More...

Shares of Amazon AMZN have fallen over 4% in the last six months, while fellow tech giants helped drive the S&P 500’s 10% climb. It appears that investors are worried about Amazon’s profit. But how long will Amazon stock stay stagnant as the e-commerce powerhouse spends to speed up its delivery?

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Amazon Worries?” data-reactid=”12″>Amazon Worries?

Amazon in the third quarter posted its first year over year earnings decline since 2017. AMZN’s adjusted EPS figure slipped 26% from Q3 2018 and fell short of our Zacks estimates. The third quarter disappointment came after the firm missed bottom-line estimates in the second quarter and ended its streak of record quarterly profits.

Wall Street appears to have voiced its concern for Amazon’s profits pullback. But the company’s bottom-line fell, in part, because it decided to spend heavily to introduce one-day shipping. AMZN’s Q3 shipping costs soared 46% to $9.6 billion from a year earlier.

These efforts are expected to help Amazon in the long run as it fights back against Walmart WMT, Target TGT, Costco COST, and others who have bolstered their businesses through an array of e-commerce, delivery, and pick-up offerings.

Jeff Bezos said last quarter that the transition of Prime shipping from two-day to one-day is vital. “It’s a big investment, and it’s the right long-term decision for customers,” Amazon’s CEO said in prepared Q3 remarks.

 

 

 

 

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Other Fundamentals ” data-reactid=”28″>Other Fundamentals

Investors are also concerned about Amazon’s slowing top-line growth. Amazon’s high-margin cloud computing business, which has helped drive its expansion for years, grew at its slowest pace in six quarters in Q3 FY19. AWS still climbed 35%, but this was down from Q3 FY18’s 46%.

Luckily, Amazon’s digital ad-heavy “other” division helped pick up some of the slack, with sales up 45%. In fact, Amazon is projected to grab the third-largest share of U.S. digital ad dollars in 2019, behind only Google GOOGL and Facebook FB. Plus, AMZN’s high-margin cloud business will likely continue to help it expand into new growth areas, from pharmaceuticals to logistics.

Amazon’s streaming TV business might also remain attractive in a crowded market alongside Netflix NFLX and others given its commitment to spending on original content and a mixture of live sports, including some NFL and soccer.

We can see from the nearby chart that AMZN stock rests below its fall-2018 highs. Amazon stock closed regular trading Monday around 10% off its highs at around $1,828 per share.

And for those that take a more technical approach, AMZN just dipped under its 200-day moving average after bouncing through it in late December. The stock might find support soon at its 50-day moving average. But the technicals might not matter with Amazon set to report.

Meanwhile, Amazon is currently trading at 2.7X forward 12-month sales estimates. This marks a discount against its industry’s 4X average and its own three-year median of 2.8X and 3.7X high.

 

 

 

 

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Outlook ” data-reactid=”50″>Outlook

Amazon’s adjusted Q4 earnings are projected to slip 34%, based on our Zacks estimates. This would mark a larger downturn than last quarter. However, its adjusted full-year earnings are projected to pop 1.8%. Then, the e-commerce firm’s 2020 EPS figure is expected to surge 28% above our current-year estimate.  

On the top line, Amazon’s fourth quarter sales are projected to jump 18.8%, with FY19’s revenues set to surge roughly 20% to reach $279.11 billion. The company’s 2020 sales are then expected to climb another $52 billion, or 18.5%, above our current-year estimate to come in at a whopping $330.95 billion.

These revenue figures would mark a slowdown compared to Amazon’s sales growth from 2018 through 2016, which came in at approximately 30%. Peeking further back, our 2019 and 2020 sales estimates would roughly match 2015-2013’s revenue expansion.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Bottom Line” data-reactid=”54″>Bottom Line

Amazon is set to report its Q4 financial results after the closing bell on Thursday, January 30. AMZN is currently a Zacks Rank #3 (Hold) that holds a “D” grade for Value and an “F” for Momentum in our Style Scores system.

Investors likely want to take a wait-and-see approach, given the current market conditions and the fact that Amazon has underperformed the market for months.

However, it does seem hard to imagine that Amazon stock will stay down for that much longer. And its upcoming earnings report could be a catalyst, which means investors need to pay close attention to guidance and how Wall Street reacts in the days following the release. 

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now&gt;&gt;” data-reactid=”58″>Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
&nbsp;
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
&nbsp;
Netflix, Inc. (NFLX) : Free Stock Analysis Report
&nbsp;
Facebook, Inc. (FB) : Free Stock Analysis Report
&nbsp;
Alphabet Inc. (GOOGL) : Free Stock Analysis Report
&nbsp;
Costco Wholesale Corporation (COST) : Free Stock Analysis Report
&nbsp;
Walmart Inc. (WMT) : Free Stock Analysis Report
&nbsp;
Target Corporation (TGT) : Free Stock Analysis Report
&nbsp;
To read this article on Zacks.com click here.
&nbsp;
Zacks Investment Research” data-reactid=”59″>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
 
Netflix, Inc. (NFLX) : Free Stock Analysis Report
 
Facebook, Inc. (FB) : Free Stock Analysis Report
 
Alphabet Inc. (GOOGL) : Free Stock Analysis Report
 
Costco Wholesale Corporation (COST) : Free Stock Analysis Report
 
Walmart Inc. (WMT) : Free Stock Analysis Report
 
Target Corporation (TGT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Read More

Add Comment

Click here to post a comment